ClinicalTrials.gov
public full text
Public Domain
Rifaximin in Fatty Liver Disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids#802894
- Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease#856958
- Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis#1121774
- Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients#967675
- Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD#267991
Record · ID 158000
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive